SIRO and AZIDUS enter into an alliance
The partnership will help expand services and market share for both the CROs
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
AstraZeneca stops COVID-19 vaccine trial due to unexplained illness in participant
A participant was found to have transverse myelitis, an inflammatory syndrome that affects the spinal cord and is often sparked by…
NPPA is readying mechanism to ease COVID-19 vaccine supply, prevent unethical practices
The government is in talks with experts and stakeholders to increase access to COVID-19 vaccines, bring down their costs and…
Nine COVID-19 vaccine makers sign safety pledge
The companies said in a statement they would uphold the integrity of the scientific process as they work towards potential global…
E-pharma set to revolutionise drug market access in India: GlobalData
E-pharma companies will offer competitive pricing and access to quality medicines even in remote places along with the ease of…
Takeda sells select non-core assets in Europe to Cheplapharm for about $562 mn
Portfolio includes prescription products in Takeda’s cardiovascular/metabolic and anti-inflammatory therapeutic areas along with…
India ramping up API manufacturing: NITI Aayog CEO
The Indian government is committed to achieving its ''Pharma Vision 2020'', which aims to make the country a global leader in drug…
Intravacc gets US NIAID contract to develop enterovirus D68 vaccine
EV D68 is a respiratory virus that can cause childhood paralysis, acute flaccid myelitis
Mylan to acquire thrombosis business in Europe from Aspen Pharmacare for EUR 641.9 mn
Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS
UPSIDA organises webinar to attract investors for proposed bulk drug park in Lalitpur
State authorities highlight initiatives that will be taken to create advantages for investors; stakeholders recommend measures to…
Dr Reddy’s Laboratories launches Fulvestrant Injection in US
Fulvestrant is an estrogen receptor antagonist indicated for the treatment of HR-positive advanced breast cancer
Surfing the digital wave in pharma retail
The pharma retail space has had a digital component to it for quite a while, but the pandemic has served notice to the laggards in…
CORONA Remedies picks up stake in La Chandra Pharmalab
La Chandra Pharmalab is a manufacturer and supplier of pregnancy care drug progesterone and a range of hormone APIs
Janssen gets EC approval for expanded use of IMBRUVICA (ibrutinib) plus rituximab to treat CLL
Data from Phase 3 E1912 study showed previously untreated patients aged 70 years or younger treated with ibrutinib plus rituximab…
Hamdard Labs starts clinical trials of two drugs to evaluate efficacy to prevent COVID-19 infection
After regulatory approval from AYUSH ministry, the clinical trials are being conducted at HAH Centenary Hospital, New Delhi
Alembic Pharma gets tentative USFDA approval for Treprostinil injection
It is indicated for the treatment of pulmonary arterial hypertension to diminish symptoms associated with exercise
UNICEF to pilot acquisition, distribution of COVID-19 vaccines
The effort, involving over 170 economies, has the potential to become the world's largest and fastest ever operation of its kind
BPPI records sales turnover of Rs 146.59 cr in first quarter of 2020-21
The total sales up to July 31, 2020, stood at Rs 191.90 crores
Bharat Biotech gets DCGI nod for PHASE II trials of COVAXIN
The subject expert committee (SEC) has recommended that the trial will be conducted on 380 participants
Fighting fakes with technology
Vinod Kumar Arora, Principal Advisor, Institute of Good Manufacturing Practices India (IGMPI) states that the time has come when…